Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AWL-II-38.3 is a highly effective inhibitor of EphA3, a receptor for ephrin-A. It demonstrates potent kinase inhibitory activity against EphA3 and does not show significant cellular activity against Src-family kinases or b-raf [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 74.00 | |
5 mg | In stock | $ 178.00 | |
10 mg | In stock | $ 278.00 | |
25 mg | In stock | $ 572.00 | |
50 mg | In stock | $ 822.00 | |
100 mg | In stock | $ 1,130.00 | |
500 mg | In stock | $ 2,280.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 186.00 |
Description | AWL-II-38.3 is a highly effective inhibitor of EphA3, a receptor for ephrin-A. It demonstrates potent kinase inhibitory activity against EphA3 and does not show significant cellular activity against Src-family kinases or b-raf [1] [2]. |
In vitro | AWL-II-38.3 fits to LIMK2 and LIMK1 ATP-binding and substrate-binding pockets [2] . |
Molecular Weight | 469.42 |
Formula | C23H18F3N5O3 |
CAS No. | 1135205-94-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 65 mg/mL (138.47 mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AWL-II-38.3 1135205-94-5 Tyrosine Kinase/Adaptors Ephrin Receptor inhibit AWL II 38.3 LIMK1 Inhibitor LIMK2 EphA3 ATP AWLII38.3 inhibitor